Expand Your Capabilities and Speed Time-to-Clinic With the Perfect Combination of Technology and Expertise
Get Insight Into the Facility of Our Trusted Cell Line Development Services
When it comes to the commercialization of biologics, effective, high-quality cell line development (CLD) is essential for success. The key to minimizing risk and optimizing outcomes is having a reliable partner that offers both cell line development experience and expertise and a comprehensive portfolio of innovative products and services that help take your molecule from DNA to GMP Master Cell Bank.
This webinar will highlight the cell line development workflow required to produce stable and scalable clones that are ready to be used in a clinical or commercial setting. It will review the full suite of Sartorius’ CLD services, including bioanalytical testing, master cell banking and biosafety testing, as well as the extensive cell line development experience we bring to every project.
You will be introduced to Sartorius experts who can answer your questions, and you will learn about our state-of-the-art Cell Culture Technology Center in Ulm, Germany, which features special laboratories designed to develop cell lines and optimize cell culture media.
What Will You Learn:
- Understand the drug development process, from cell line development (CLD) to Master Cell Bank
- Explore the benefits of outsourcing cell line development to an external partner such as Sartorius
- Identify what to consider when evaluating external providers of CLD products and services
- Learn about Sartorius’ CLD Protein Expression technology and capabilities
Meet Our Expert:
Ademola Kassim, MBA
Product Specialist, Cell Line Development, Sartorius
Ademola Kassim is Product Specialist for Cell Line Development within the Cell Line, Media, and Testing Solutions (CMTS) division at Sartorius. Ademola holds a BS in Biology from the University of Missouri, MS in Medical Biotechnology from the University of Illinois, and an MBA from Webster University.
He has over ten years’ experience within the bioprocessing industry. Prior to Sartorius, Ademola was a Product Manager at MilliporeSigma, where he helped develop and manage a portfolio of cell lines, cell culture media and bioprocess services commonly used in the biopharmaceutical industry. Before this role, he worked in Cell Line Development and Engineering as an R&D Scientist developing a variety of CHO cell lines for the efficient manufacturing of recombinant proteins.